CLINICAL_TRIALS
trial_result
· 2014-11-25
Clinical Trial Update: Dexpramipexole SAD/MAD Study [Phase 1]
Summary
This document announces the completion of a Phase 1 SAD/MAD study of dexpramipexole for amyotrophic lateral sclerosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Knopp Biosciences | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: COMPLETED